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Abstract
Alpinia galanga oil (AGO) possesses various activities but low aqueous solubility limits its
application particularly in aquatic animals. AGO has powerful activity on fish anesthesia.
Ethanol used for enhancing water miscible of AGO always shows severe side effects on
fish. The present study explores the development of self-microemulsifying drug delivery sys-
tems (SMEDDS) and nanoemulsions (NE) to deliver AGO for fish anesthesia with less or no
alcohol. Pseudoternary phase diagrams were constructed to identify the best SMEDDS-
AGO formulation, whereas NE-AGO were developed by means of high-energy emulsifi-
cation. The mean droplet size of the best SMEDDS-AGO was 82 ± 0.5 nm whereas that of
NE-AGO was 48 ± 1.6 nm. The anesthetic effect of the developed SMEDDS-AGO and NE-
AGO in koi (Cyprinus carpio) was evaluated and compared with AGO ethanolic solution
(EtOH-AGO). It was found that the time of induction the fish to reach the surgical stage of
anesthesia was dose dependent. NE-AGO showed significantly higher activity than
SMEDDS-AGO and EtOH-AGO, respectively. EtOH-AGO caused unwanted hyperactivity
in the fish. This side effect did not occur in the fish anesthetized with SMEDDS-AGO and
NE-AGO. In conclusion, SMEDDS and NE are promising delivery systems for AGO.
Introduction
Alpinia galanga is a plant in family Zingiberaceae. Many parts of A. galanga such as rhizome,
flower, and young leaf are edible and have been used in Asian folk medicinal and food reme-
dies. A. galanga oil (AGO) has wonderful essence that can enhance the flavor of foods and ele-
vate them to a level of brightness. AGO has been extensively used in traditional treatment of
stomach ache and diarrhea [1]. Previous studies reported several biological properties of AGO
on anti-bacterial, anti-oxidant, and anti-inflammatory activities [2–5]. Interestingly, we have
recently found that AGO has excellent action on fish anesthesia [6]. However, the poor water
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miscibility of AGO causes limitations in its application, particularly in animals for which water
is the essential environment, such as fish.
Absolute ethanol has been used to increase the water miscibility of AGO for fish anesthesia
but alcohol causes several side effects in fish, such as hyperactivity, a constellation of congenital
and retinal anomalies, and central nervous system (CNS) deficits. Ethanol has also been found
to induce stress proteins in zebrafish embryos [7–10]. If we can build up an innovative tech-
nology to improve the miscibility of AGO in water and avoid using alcohol, we may solve the
two main problems (poor solubility in water of AGO and side effect of alcohol) at the same
time. Nanoformulations such as self-microemulsifying drug delivery systems (SMEDDS) and
nanoemulsions (NE) have been reported to be able to solubilize and stabilize hydrophobic
active ingredients and to enhance the bioavailability of many water insoluble compounds [11–
14]. Furthermore, SMEDDS and NE have been shown to enhance the biological activity of nat-
ural compounds [15–18].
The objective of the present study was to develop and characterize SMEDDS and NE con-
taining AGO (SMEDDS-AGO and NE-AGO) in order to increase AGO water miscibility and
to decrease the use of ethanol in fish anesthesia. The effects of type and amount of surfactant
used in the developed SMEDDS-AGO and NE-AGO on the phase behavior of the oil/water
systems were investigated. In addition, this study also investigated the anesthetic effect of the
developed SMEDDS-AGO and NE-AGO in comparison with AGO ethanolic solution (EtO-
H-AGO) on fish using koi (Cyprinus carpio) as an animal model.
Materials and methods
Materials
Fresh rhizomes of A. galanga were collected in December 2015 from the medicinal garden,
Chiang Mai, Thailand. The plant voucher specimen no. 009245 was deposited at the Herbar-
ium, Northern Research Center for Medicinal Plants, Faculty of Pharmacy, Chiang Mai Uni-
versity, Thailand. Polyoxyethylene sorbitan monolaurate (Tween 20) and polyoxyethylene
sorbitan monooleate (Tween 80) were from Merck (Hohenbrunn, Germany) while polyox-
yethylene octylphenyl ether (Triton X-100) was obtained from Amresco (Cleveland, OH,
USA). Absolute ethanol, dichloromethane, and hexane were of analytical grade and were sup-
plied by Merck Millipore (Darmstadt, Germany). Isopropanol was purchased from Labscan
Analytical Science (Bangkok, Thailand). Propylene glycol was from Sigma-Aldrich (St. Louis,
MO, USA). All other chemicals and solvents were of the highest grade available.
Extraction and chemical analysis of AGO
Fresh rhizomes of A. galanga were cut into small pieces and subjected to hydrodistillation for 3
h using a Clevenger apparatus for oil collection. The experiment was done in triplicate. The
yield of the oil obtained from each experiment was recorded and the average yield value was
calculated. The volatile oil obtained was stored in a refrigerator at –20˚C and protected from
light until use. AGO was analyzed for its chemical composition using gas chromatography-
mass spectrometry (GC-MS). An Agilent 6890 gas chromatograph was coupled to an electron
impact (EI, 70 eV) using a Hewlett Packard (HP) mass selective detector (MSD), model HP
5973-MSD and fitted with a fused silica capillary column (HP5-MSI; 30.0 m × 0.25 mm i.d. ×
0.25 μm film thickness) (Agilent Technologies Inc, USA). The analytical protocol was stan-
dardized from previous studies with some modification [19]. Briefly, 1 μL of AGO 1:100 (v/v)
diluted with dichloromethane was injected. Identification of the compounds of interest was
performed based on comparing retention times to those of reference spectra obtained from
two mass spectral databases (Wiley and the National Institute of Standards and Technology;
SMEDDS and NE for Alpinia galanga oil
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NIST). The Wiley database is the largest database of its kind and the NIST mass spectral data-
base contains approximately 62,000 mass spectra of an equal number of chemicals [20]. These
two mass spectral databases are commonly applied for identifying bioactive compounds in
natural plants [21–22]. The percentage of each compound was calculated based on the total
area of all peaks obtained from the oil.
Preparation of SMEDDS-AGO
Pseudoternary phase diagrams of AGO were constructed using an aqueous titration method.
To obtain the surfactant mixture (Smix), surfactant (Tween 20, Tween 80, or Triton X-100) and
cosurfactant (absolute ethanol, propylene glycol, or isopropanol) were mixed at weight ratios of
1:2, 1:1, and 2:1. Then, AGO and Smix were mixed at weight ratios of 0:1, 1:9, 2:8, 3:7, 4:6, 5:5,
6:4, 7:3, 8:2, 9:1 and 1:0. The resulting mixtures were subsequently titrated with water under
moderate agitation at ambient temperature. Clear, monophasic liquid samples were classified as
microemulsions (ME). All formulations were prepared in triplicate. The pseudoternary phase
diagrams were designed using OriginPro8 for Windows (OriginLab Corporation, USA).
Selected formulations of SMEDDS-AGO were then prepared by mixing AGO and several
Smix, based on the pseudoternary phase diagrams. Smix was prepared before mixing with
AGO using a vortex mixer to the desired weight ratios before transferring to glass vials for fur-
ther use.
Preparation of NE-AGO
Six formulations of NE-AGO (A, B, C, D, E, and F), composed of 20% AGO, were prepared by
means of high-energy emulsification using three different surfactants; Tween 20, Tween 80,
and Triton X-100. NE-AGO-A and NE-AGO-B contained 5% and 10% Tween 20, respectively
whereas NE-AGO-C and NE-AGO-D contained 5% and 10% Tween 80, respectively and
NE-AGO-E and NE-AGO-F contained 5% and 10% Triton X-100, respectively. An emulsion
inversion point method (EIP) was used to prepare the pre-emulsions. Briefly, the water phase
was added to the oil phase under stirring at 50˚C for 5 min before subjecting the mixture to
high speed stirring using an Ultra-Turrax T25 (Janke and Kunkel GmbH, Germany) at 16,000
rpm for 5 min. The pre-emulsions obtained (20 g) were then passed through a high pressure
homogenizer (HPH) (Avestin Inc., Canada) using various homogenization cycles (1, 3, 5, 7,
10, 15, and 20 cycles) with approximately 1–2 min/cycle and pressures of 5,000 and 10,000 psi
at room temperature. The experiments were performed at ambient temperature in triplicate.
Droplet size and zeta potential
The droplet size and size distribution (expressed as polydispersity index, PdI) as well as the
zeta potential (ZP) of SMEDDS-AGO and NE-AGO were measured using photon correlation
spectroscopy (Zetasizer Nano ZS, Malvern Instruments Ltd., UK). The size measurements
were carried out at a fixed angle of 173˚ at 25˚C. All formulations were diluted with distilled
water at a ratio of 1:100 (v/v) before measurement. All measurements were carried out in
triplicate.
Conductivity study
The electrical conductivity of SMEDDS-AGO and NE-AGO was measured using a conductiv-
ity meter EX-20 (Horiba, Japan). The formulations were diluted in distilled water at a ratio of
1:100 (v/v) before measuring. The conductivity meter was calibrated using a standard solution
of 1413 μS/cm (Eutech Instruments) before testing. The experiments were performed at 25˚C
SMEDDS and NE for Alpinia galanga oil
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by dipping the electrode into the test sample until equilibrium was reached and the readings
became stable. All measurements were carried out in triplicate.
Stability study
All SMEDDS-AGO, and NE-AGO formulations were kept at three storage temperatures, 4˚C,
20˚C, and 40˚C, for one month. Changes in optical appearance such as phase separation, color
changes, and turbidity were observed visually. The droplet size of the formulations was deter-
mined after dispersion the stored samples in distilled water (1:100 v/v) and compared with
that of freshly prepared samples investigated in the same manner.
The selected SMEDDS-AGO and NE-AGO kept at different storage conditions (4˚C, 20˚C,
and 40˚C) were analyzed for chemical changes using gas chromatography in comparison with
AGO. For the SMEDDS-AGO formulations, hexane was added to all samples to get 1:100 dilu-
tions. The diluted samples were mixed using a vortex mixer for 5 min and centrifuged at
13,000 rpm for 1 min. One μL of the supernatant was injected into an Agilent 6890 gas chro-
matograph equipped with a fused silica capillary column (HP5; 30.0 m × 0.25 mm i.d. ×
0.25 μm film thickness) from Agilent Technologies Inc, USA, using flame ionization for detec-
tion. For the NE-AGO formulations, all samples were firstly diluted with hexane at a ratio of
1:1 (v/v). Subsequently, the hexane layer was separated and further diluted 100 fold with pure
hexane. One μL of the diluted sample was injected into the Agilent 6890 gas chromatograph
using the same conditions as described above. All experiments were performed in triplicate.
Fish and culture condition
Juvenile Cyprinus carpio or koi, with an average weight and length of 9.6 ± 0.1 g and 10.9 ± 0.2
cm respectively, were purchased from a local ornamental fish shop in Thailand, and used in
the anesthetic study. The fish were maintained in continuously aerated tanks (500 L) with con-
trolled dechlorinated tap water (temperature 25˚C; pH 7.4; total hardness 110 ppm; alkalinity
90 ppm; total ammonia nitrogen and nitrite were negative) for 2–4 weeks before being used in
the anesthetic study. 50% of fresh water was changed daily. The fish were fed twice daily with a
commercial dry feed (INTEQC Feed, Thailand) and held in natural light conditions. All exper-
imental methods were approved by the Animal Care Committee of the Faculty of Veterinary
Medicine, Chiang Mai University (FVM-ACUC no. R3/2555).
Anesthetic effects
Experiments were conducted in glass aquaria (100 × 100 × 150 mm), containing 1 L of dechlo-
rinated tap water. EtOH-AGO, 1:10 v/v dilution in absolute ethanol, was used as a positive
control. The selected SMEDDS-AGO and NE-AGO at various concentrations (100, 200, 300,
and 400 mg/L) of AGO and EtOH-AGO were added to the aquaria. The fish were divided into
12 groups of 20 individual fish for each treatment and concentration (n = 20). The fish were
selected randomly and used only once. The criteria to determine the anesthetic effects were
based on the fish behavioral responses [23]. The surgical stage where the fish reaches stage 3
plane 2 is the most important for evaluating the efficacy of the anesthetics because at this stage
the fish stops any swimming activity, shows loss of equilibrium and loss of responsiveness and
is thus easy to handle in routine operations, such as netting, weighing, sorting, operations, vac-
cinations, and transportation. To evaluate the time required for the induction of fish anesthesia
into stage 3 plane 2, the fish were individually anesthetized by each formulation with various
AGO concentrations. Furthermore, the anesthetic behavioral changes such as hyperactivity
(fish exciting and increased swimming activity), jumping (fish jumping out of water) and pip-
ing (fish piping for air near water surface) were also recorded by clinical observation. Each fish
SMEDDS and NE for Alpinia galanga oil
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was used only once. The maximum observation time was 20 min. When the fish reached the
surgical anesthesia stage, they were immediately transferred to anesthetic-free aquaria to mea-
sure the recovery time. At the end of the experiment period, the survived fish were maintained
in laboratory until they were in healthy condition with no biohazard contamination and then
were donated to the aquarist as pet fish.
Statistical analysis
The data are presented as means ± S.E.M. Kolmogorov-Smirnov’s test was used to evaluate
normality of the data distribution. Data was then analyzed by an independent t-test or a one-
way ANOVA followed by Tukey’s post-hoc test. Statistical significance was considered at
p-values< 0.05.
Results and discussion
Chemical analysis of AGO
The yield of AGO from the extraction of the fresh rhizomes of A. galanga was 0.10% v/w. The
AGO obtained was a clear, pale yellow liquid. Twenty-six compounds representing 91.42% of
the total composition obtained from this oil were identified by GC-MS analysis (Table 1). The
main constituents of the extract were oxygenated monoterpenes (1,8-cineole, 37.43%) and
phenylpropanoids (4-allylphenyl acetate, 25.97%), which is in agreement with previous reports
[24, 25]. Slight differences to the reported chemical compositions of AGO [26–28] are caused
by geographic, physiological and genetic variations of the plant material [29].
Preparation of SMEDDS-AGO
Pseudoternary phase diagrams were constructed to identify the desired SMEDDS regions and
to optimize the ratio of oil (AGO), surfactant, and cosurfactant [30]. Initially, the effect of sur-
factant without cosurfactant on creating a monophasic area in the phase diagram was investi-
gated. It was found that the areas of monophasic transparent formulations using Tween 20,
Tween 80, and Triton X-100 were 32.8 ± 0.3, 21.2 ± 0.2, and 27.6 ± 0.2 percent of the total
phase diagram, respectively (Fig 1). Thus the results indicate that among the three nonionic
surfactants used, Tween 20 created the largest monophasic area in the phase diagrams.
The use of a single surfactant without cosurfactant is usually not sufficient to reduce the
interfacial tension between oil and water to form transparent monophasic systems, at least not
in a substantial area of the phase diagram [31, 32]. Thus, the addition of a cosurfactant or
cosolvent is generally required. To investigate the effect of cosurfactant on supporting the sur-
factant to create a monophasic area in the phase diagram, three alcohols; ethanol, propylene
glycol, and isopropanol, were used in combination with the three different surfactants at a
weight ratio of 1:1, 1:2, and 2:1 (termed Smix). It was found that addition of ethanol, which is
more hydrophilic than the other two cosurfactants, resulted in the formation of the largest
monophasic area in the phase diagrams as shown in Figs 2–4, respectively. After mixing with
the cosurfactants, Triton X-100 showed the highest potential to result in a monophasic area in
the phase diagrams, followed closely by Tween 80, whereas the use of Tween 20 resulted in the
smallest monophasic area. The results also demonstrated that among the three Smix ratios
used (2:1, 1:1, and 1:2), the 2:1 mix was the most effective in creating a large monophasic area.
Characterization of SMEDDS-AGO
From the obtained pseudoternary phase diagrams, it was found that SMEDDS-AGO com-
posed of 20% of AGO and 80% of Smix (surfactant:ethanol = 2:1) constituted suitable
SMEDDS and NE for Alpinia galanga oil
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Table 1. Chemical composition of AGO.
Retention time (min) Compound Amount (%)*
4.08 α-Pinene 4.53
4.39 Camphene 0.19
4.93 Sabinene 0.32
5.03 β-Pinene 3.27
5.33 β-Myrcene 0.79
6.06 α-Terpipene 0.40
6.60 1,8-Cineole 37.43
7.02 1,3,6-Octatriene 0.03
7.35 γ-Terpinene 0.66
8.32 α-Terpinolene 0.33
11.23 Borneol 0.04
11.32 α Terpineol 2.41
11.73 Terpinen-4-ol 3.24
12.65 2-Butenal 0.22
15.23 Chavicol 1.50
18.93 4-Allylphenyl acetate 25.97
19.23 Eugenol 0.14
20.25 Geranyl acetate 0.77
21.43 Methyl eugenol 5.07
22.79 β-Selinene 0.25
23.08 β-Farnesene 0.15
23.90 Germacrene-D 0.24
25.10 β-Bisaboloene 1.10
25.66 β-Sesquiphellandrene 0.78
26.00 Eugenyl acetate 1.46
30.08 δ-Cadinene 0.13
Total 91.42
* Listed amounts are the percentage of each compound calculated based on the total area of all peaks obtained from the oil.
https://doi.org/10.1371/journal.pone.0188848.t001
Fig 1. Pseudoternary phase diagrams of AGO containing Tween 20 (a), Tween 80 (b), and Triton X-100 (c). The black area
represents the monophasic area. Asterisks (*) indicate the percentage of the monophasic area (means ± S.E.M.).
https://doi.org/10.1371/journal.pone.0188848.g001
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formulations for further characterization. Although using Triton X-100 with ethanol at a
weight ratio of 2:1 yielded the largest monophasic area in the phase diagrams, Tween 80 was
chosen instead of Triton X-100 because it is less irritating and less toxic than Triton X-100
[33]. Thus, SMEDDS-AGO composed of 20% of AGO and 80% of Smix (Tween 80:etha-
nol = 2:1) was selected for further characterization. The visual appearance of this SMEDD-
S-AGO formulation was that of a clear, pale yellowish solution. After 100-fold water dilution,
it was found that the average droplet size was 82 ± 0.5 nm with a PdI of 0.38 ± 0.02. The high
PdI indicated a fairly broad size distribution in the formulation. Zeta potential, and conductiv-
ity of this formulation were –10.40 ± 0.20 mV and 297.7 ± 1.76 μS/cm, respectively. The zeta
potential is one of the factors that influences the physical stability of the dispersed droplets,
with high positive or negative values (higher than +30 mV or –30 mV, respectively) usually
Fig 2. Pseudoternary phase diagrams of AGO using surfactant:ethanol at a weight ratio of 1:1 (a, d, g), 1:2 (b, e, h), and 2:1 (c,
f, i) for Tween 20 (a, b, c), Tween 80 (d, e, f), and Triton X-100 (g, h, i). The black area represents the monophasic area. Asterisks
(*) indicate the percentage of the monophasic area (means ± S.E.M.).
https://doi.org/10.1371/journal.pone.0188848.g002
SMEDDS and NE for Alpinia galanga oil
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leading to higher physical stability [34]. In this study, diluted SMEDDS showed zeta potential
values of less than –30 mV due to the use of a nonionic surfactant. The physical stability of the
dispersed droplets of the diluted SMEDDS was however, still high due to steric stabilization of
the nonionic surfactant used [35]. The high conductivity value of this formulation confirmed
its expected O/W phase behavior.
Preparation and characterization of NE-AGO
NE formulations are emulsions with a small droplet size in the nanometer range of about 20–200
nm [36]. As can be seen in Table 2, the employed surfactants resulted in different droplet sizes for
the various NE-AGO formulations. Generally, an increase in surfactant concentrations led to a
decrease in droplet size. After using HPH at a pressure of 10,000 psi for 7 cycles, the largest droplet
Fig 3. Pseudoternary phase diagrams of AGO using surfactant:propylene glycol at a weight ratio of 1:1 (a, d, g), 1:2 (b, e,
h), and 2:1 (c, f, i) for Tween 20 (a, b, c), Tween 80 (d, e, f), and Triton X-100 (g, h, i). The black area represents the monophasic
area. Asterisks (*) indicate the percentage of the monophasic area (means ± S.E.M.).
https://doi.org/10.1371/journal.pone.0188848.g003
SMEDDS and NE for Alpinia galanga oil
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size (130 ± 0.9 nm) was obtained from NE-AGO-E using 5% of Triton X-100 as a surfactant while
NE-AGO-F, using 10% Triton X-100, gave the smallest droplet size (33 ± 0.3 nm).
HPH generated intense disruptive forces, resulting in a decreased droplet radius [37]. The
droplet size thus decreased by increasing the HPH pressure and the number of HPH cycles
(Fig 5) for NE-AGO-D. The largest decrease of the mean droplet size occurred when the pre-
emulsions were passed through the HPH (at all pressures) after the first cycle. In addition, the
droplet size of the NE-AGO continued to decrease by increasing the number of HPH cycles,
until 7–10 cycles, whereafter no further changes in droplet size were measured.
The six formulations of NE-AGO showed a white bluish color or had a translucent, bluish
appearances when 10% of Triton X-100 was used as a surfactant. As shown in Table 2, the
Fig 4. Pseudoternary phase diagrams of AGO using surfactant:isopropanol at a weight ratio of 1:1 (a, d, g), 1:2 (b, e, h),
and 2:1 (c, f, i) for Tween 20 (a, b, c), Tween 80 (d, e, f), and Triton X-100 (g, h, i). The black area represents the monophasic
area. Asterisks (*) indicate the percentage of the monophasic area (means ± S.E.M.).
https://doi.org/10.1371/journal.pone.0188848.g004
SMEDDS and NE for Alpinia galanga oil
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smallest droplet size (33 ± 0.3 nm) was obtained from NE-AGO-F while NE-AGO-E had the
largest mean droplet size (130 ± 0.9 nm). The PdI values of the NE-AGO formulations were
approximately 0.4, except for the NE-AGO composed of 5% Triton X-100 where the PdI was
about 0.3. Surprisingly, the zeta potential of all NE-AGO formulations were lower than –30
mV. Since non-ionic surfactants were used, the negative zeta potentials were considered to be
due to the spontaneous adsorption of common hydroxyl ions in the aqueous system at the o/w
interface [38]. The conductivity of all formulations was found to be higher than 100 μS/cm,
which, as expected, confirms the O/W nature of the formed NE in the present study.
Stability study
The stability results of the selected SMEDDS-AGO is shown in Table 3. The SMEDDS-AGO
showed no phase separation after one month of storage. NE-AGO-A, NE-AGO-B, NE-A-
GO-E, and NE-AGO-F showed phase separation, except NE-AGO-C and NE-AGO-D which
were formulated using Tween 80. These two formulations were further characterized and
the results are shown in Table 4. NE-AGO-D which contained 10% Tween 80 showed a
mean droplet size smaller than the NE-AGO-C that contained 5% Tween 80 at all storage
Table 2. Characterization of NE-AGO.
NE-AGO Size
(nm)
PdI Zeta potential (mV) Conductivity
(μS/cm)
NE-AGO-A 63 ± 1.6 0.38 ± 0.01 –36.3 ± 0.52 511.0 ± 0.33
NE-AGO-B 68 ± 0.9 0.34 ± 0.03 –42.70 ± 0.50 750.7 ± 0.33
NE-AGO-C 104 ± 0.5 0.42 ± 0.00 –35.43 ± 0.38 571.7 ± 0.33
NE-AGO-D 48 ± 1.6 0.43 ± 0.01 –35.07 ± 1.82 551.3 ± 0.33
NE-AGO-E 130 ± 0.9 0.23 ± 0.00 –41.83 ± 0.35 308.0 ± 1.53
NE-AGO-F 33 ± 0.3 0.39 ± 0.01 –31.83 ± 0.35 499.7 ± 0.33
Data are presented as means ± S.E.M.
https://doi.org/10.1371/journal.pone.0188848.t002
Fig 5. Effect of pressure and number of homogenization cycles on droplet size of the best NE-AGO
formulation (NE-AGO-D). Data are presented as means ±S.E.M. (p <0.05). Asterisks (*) indicate a significant
difference between the obtained NE-AGO-D after using a pressure of 5,000 and 10,000 psi (p <0.05). The
dataset is available in S1 Dataset.
https://doi.org/10.1371/journal.pone.0188848.g005
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temperatures. Stored for one month, the mean droplet size of NE-AGO-D increased from
48 ± 1.6 nm to 78 ± 2.3 nm at 4˚C and to 116 ± 1.2 nm at 40˚C. However, the mean droplet
size of the formulation stored at 20˚C changed only slightly from 48 ± 1.6 nm to 66.1 ± 2.4 nm
within one month of storage. Due to its small droplet size, NE-AGO-D was selected for further
investigation of chemical stability.
For SMEDDS-AGO, during one month of storage at 20˚C, the droplet size of the ME for-
mulation obtained from 1:100 v/v aqueous dilutions before size measurement did not change.
On the other hand, the ME formulations obtained from the SMEDDS-AGO stored at 4˚C and
40˚C showed an increase in the mean droplet size compared to freshly prepared samples
(82 ± 0.5 nm) to 142 ± 5.3 nm and 106 ± 1.5 nm, respectively. The storage temperature and
time had no influence on the zeta potential of both SMEDDS-AGO and NE-AGO.
After storage of AGO, SMEDDS-AGO, and NE-AGO-D at 4˚C, 20˚C and 40˚C for 12
weeks, the content of 1,8-cineole and 4-allylphenyl acetate (the main compounds in AGO) was
found to have decreased (Figs 6 and 7) and 58%, 60%, and 46% of the initial levels of 1,8-cine-
ole and 55%, 57%, and 46% of the initial levels of 4-allylphenyl acetate were retained in NE-A-
GO-D stored at 4˚C, 20˚C, and 40˚C, respectively. The decrease of 1,8-cineole content of
NE-AGO-D can be explained by oxidation [39] whereas the decrease in 4-allylphenyl acetate
content of NE-AGO-D can be explained by hydrolytic degradation in the presence of water in
the NE formulation [39, 40]. Moreover, degradation of 1,8-cineole has been reported when the
compound was entrapped in a microencapsulated formulation [41, 42]. In contrast, both com-
pounds; 1,8-cineole and 4-allylphenyl acetate, in AGO and SMEDDS-AGO only slightly
decreased by not more than 10% of the initial levels at 4˚C and 20˚C during 12 weeks of stor-
age as seen in Figs 6 and 7, respectively. Thus the presence of water in the formulation was the
main problem for AGO stability and SMEDDS demonstrated to be the most stable of the stud-
ied systems.
Table 3. Characterization of SMEDDS-AGO kept at different temperature for 1 month.
Temperature
(˚C)
Size
(nm)
PdI Zeta potential (mV) Conductivity
(μS/cm)
4 142 ± 5.3 0.47 ± 0.08 –12.43 ± 1.01 311.0 ± 0.60
20 92 ± 0.8 0.47 ± 0.02 –8.39 ± 0.51 297.1 ± 2.38
40 106 ± 1.5 0.44 ± 0.03 –9.51 ± 0.44 291.13 ± 1.44
Data are presented as means ± S.E.M.
https://doi.org/10.1371/journal.pone.0188848.t003
Table 4. Characterization of NE-AGO kept at different temperature for 1 month.
NE-AGOa Temperature
(˚C)
Size
(nm)
PdI Zeta potential (mV) Conductivity
(μS/cm)
NE-AGO-C 4 204 ± 1.7 0.55 ± 0.03 –38.83 ± 0.92 308.3 ± 2.33
20 144 ± 1.0 0.48 ± 0.02 –21.10 ± 1.14 384.0 ± 1.53
40 110 ± 1.5 0.46 ± 0.01 –13.30 ± 0.44 484.3 ± 2.19
NE-AGO-D 4 78 ± 2.3 0.50 ± 0.02 –25.50 ± 1.15 321.0 ± 1.15
20 66 ± 2.4 0.36 ± 0.04 –27.51 ± 0.45 356.0 ± 3.21
40 116 ± 1.2 0.29 ± 0.01 –22.37 ± 0.82 436.3 ± 2.67
Data are presented as means ± S.E.M.
a
= NE-AGO-A, NE-AGO-B, NE-AGO-E, and NE-AGO-F were not determined due to phase separation.
https://doi.org/10.1371/journal.pone.0188848.t004
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Anesthetic effect
Several reports have shown that SMEDDS and NE are systems that can enhance the biological
activity of natural compounds [16, 17, 43–46]. Thus, the anesthetic effect of SMEDDS-AGO
and NE-AGO-D on Cyprinus carpio in comparison with EtOH-AGO was investigated and the
Fig 6. Chemical stability of 1,8-cineole in SMEDDS-AGO, NE-AGO-D, and AGO at 4˚C (a), 20˚C (b), and
40˚C (c). Data are presented as means ± S.E.M. Asterisks (*) indicate significant difference between AGO
and the developed formulations (SMEDDS-AGO and NE-AGO-D) (p <0.05). The dataset is available in S2
Dataset.
https://doi.org/10.1371/journal.pone.0188848.g006
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results are shown in Fig 8. Both of the developed nanoformulations (SMEDDS-AGO and
NE-AGO-D) have a higher anesthetic activity than EtOH-AGO as the induction times of
SMEDDS-AGO and NE-AGO-D to reach the surgical anesthesia stage were significantly
shorter than those of EtOH-AGO (p<0.05) at equal concentrations of AGO (200, 300, and
400 mg/L). However, at a concentration of 100 mg/L, neither EtOH-AGO nor SMEDDS-AGO
could induce the fish to stage 3 plane 2 anesthesia which is the surgical stage [23] within an
Fig 7. Chemical stability of 4-allylphenyl acetate in SMEDDS-AGO, NE-AGO-D, and AGO at 4˚C (a),
20˚C (b), and 40˚C (c). Data are presented as means ± S.E.M. Asterisks (*) indicate significant difference
between AGO and the developed formulations (SMEDDS-AGO and NE-AGO-D) (p <0.05). The dataset is
available in S3 Dataset.
https://doi.org/10.1371/journal.pone.0188848.g007
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evaluation period of 20 min. Interestingly, at AGO concentration of 100 mg/L using NE-A-
GO-D, the fish reached the surgical anesthesia stage within approximately 340 sec. At AGO
concentrations of 300 and 400 mg/L, NE-AGO-D also showed the highest activity. The fish
anesthetized with SMEDDS-AGO or NE-AGO-D at AGO concentrations of 200, 300, and 400
mg/L showed longer recovery times than those anesthetized with EtOH-AGO (p<0.05). The
Fig 8. Induction time (A) and recovery time (B) for Cyprinus carpio (n = 20) exposed to 100, 200, 300,
and 400 mg/L of AGO in SMEDDS-AGO and NE-AGO-D in comparison with EtOH-AGO to reach the
surgical anesthesia stage. Data are presented as means ± S.E.M. Asterisks (*) indicate a significant
difference between EtOH-AGO and the developed formulations (SMEDDS-AGO and NE-AGO-D) (p <0.05).
The dataset is available in S4 Dataset.
https://doi.org/10.1371/journal.pone.0188848.g008
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recovery times of the fish after SMEDDS-AGO and NE-AGO-D exposure were similar for
every AGO concentration tested. After monitoring for 2 weeks, no mortality of the fish
occurred after exposure to all selected formulations (SMEDDS-AGO, NE-AGO-D, and EtO-
H-AGO). Interestingly, it was noted that EtOH-AGO caused unwanted hyperactivity in the
fish as seen in Table 5. This side effect did not occur in the fish anesthetized with SMEDD-
S-AGO and NE-AGO formulations. The results of the present study demonstrated that
SMEDDS-AGO and NE-AGO-D enhanced water miscible of AGO and gave higher anesthetic
activity with significantly less side effects than EtOH-AGO. The higher anesthetic activity of
NE-AGO-D than SMEDDS-AGO was considered to be due to an influence of the droplet size
which was significantly smaller for NE-AGO-D than for ME obtained from water dilution of
SMEDDS-AGO. No mortality was observed during experimental periods.
Conclusion
We have successfully developed SMEDDS-AGO and NE-AGO formulations for enhancing
aqueous miscibility of AGO with the avoidance or limitation of alcohol in the formulations.
We demonstrate that surfactant and cosurfactant types as well as their composition ratios play
an important role for SMEDDS-AGO and NE-AGO formation and stability. We show that
water miscibility of AGO can be significantly enhanced by the developed SMEDDS-AGO and
NE-AGO formulations. The most suitable formulation for fish anesthesia of SMEDDS-AGO is
composed of 20% AGO and 80% surfactant mixture containing 2:1 ratio of Tween 80:ethanol
whereas that of NE-AGO is composed of 20% AGO, 10% Tween 80 and 70% water. These
nanoformulations showed extremely higher efficacy and significantly less side effect than EtO-
H-AGO. We conclude that SMEDDS and NE are the promising delivery systems for AGO to
enhance water miscibility, decrease the use of alcohol in the formulations, and enhance biolog-
ical efficacy of AGO.
Supporting information
S1 Dataset. Droplet size of the best NE-AGO formulation (NE-AGO-D) after passing
HPH.
(XLSX)
Table 5. Anesthetic behavioral changes of Cyprinus carpio exposed to 100, 200, 300, and 400 mg/L of AGO in SMEDDS-AGO and NE-AGO-D in
comparison with EtOH-AGO. The dataset is available in S5 Dataset.
Treatment Concentration (mg/L) Anesthetic behavioral changes
Hyperactivity Jumping Piping
No. (%) No. (%) No. (%)
SMEDDS-AGO 100 0 (0%) 0 (0%) 0 (0%)
200 0 (0%) 0 (0%) 0 (0%)
300 0 (0%) 0 (0%) 0 (0%)
400 0 (0%) 0 (0%) 0 (0%)
NE-AGO-D 100 0 (0%) 0 (0%) 0 (0%)
200 0 (0%) 0 (0%) 0 (0%)
300 0 (0%) 0 (0%) 0 (0%)
400 0 (0%) 0 (0%) 0 (0%)
EtOH-AGO 100 7 (35%) 0 (0%) 0 (0%)
200 9 (45%) 0 (0%) 0 (0%)
300 16 (80%) 0 (0%) 0 (0%)
400 18 (90%) 1 (5%) 3 (15%)
https://doi.org/10.1371/journal.pone.0188848.t005
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S2 Dataset. The content of 1,8-cineole in SMEDDS-AGO, NE-AGO-D, and AGO at 4˚C,
20˚C, and 40˚C.
(XLSX)
S3 Dataset. The content of 4-allylphenyl acetate in SMEDDS-AGO, NE-AGO-D, and AGO
at 4˚C, 20˚C, and 40˚C.
(XLSX)
S4 Dataset. Induction time and recovery time for Cyprinus carpio exposed to 100, 200, 300,
and 400 mg/L of AGO in SMEDDS-AGO and NE-AGO-D in comparison with EtOH-AGO
to reach the surgical anesthesia stage.
(XLSX)
S5 Dataset. Anesthetic behavioral changes of Cyprinus carpio exposed to 100, 200, 300, and
400 mg/L of AGO in SMEDDS-AGO and NE-AGO-D in comparison with EtOH-AGO.
(XLSX)
Acknowledgments
The authors are grateful for the financial support from the Research and Researchers for
Industries, Thailand (grant no. PHD56I0040). We also thank Bioneer:FARMA, Faculty of
Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, the National
Research Council of Thailand, and the Research Center of Pharmaceutical Nanotechnology,
Chiang Mai University, Thailand for the equipment and facility support.
Author Contributions
Conceptualization: Anette Mu¨llertz, Thomas Rades, Siriporn Okonogi.
Data curation: Nattakanwadee Khumpirapang, Surachai Pikulkaew, Anette Mu¨llertz, Thomas
Rades, Siriporn Okonogi.
Formal analysis: Nattakanwadee Khumpirapang, Surachai Pikulkaew, Anette Mu¨llertz,
Thomas Rades, Siriporn Okonogi.
Methodology: Nattakanwadee Khumpirapang, Surachai Pikulkaew.
Resources: Anette Mu¨llertz, Thomas Rades, Siriporn Okonogi.
Supervision: Anette Mu¨llertz, Thomas Rades, Siriporn Okonogi.
Writing – original draft: Nattakanwadee Khumpirapang.
Writing – review & editing: Anette Mu¨llertz, Thomas Rades, Siriporn Okonogi.
References
1. Oonmetta-aree J, Suzuki T, Gasaluck P, Eumkeb G. Antimicrobial properties and action of galangal
(Alpinia galanga Linn.) on Staphylococcus aureus. LWT-Food Sci Technol. 2006; 39: 1214–1220.
https://doi.org/10.1016/j.lwt.2005.06.015
2. Chudiwal A, Jain D, Somani R. Alpinia galanga Willd.–an overview on phyto-pharmacological proper-
ties. Indian J Nat Prod Resour. 2010; 1: 143–149.
3. Grzanna R, Lindmark L, Frondoza CG. Ginger-an herbal medicinal product with broad anti-inflamma-
tory actions. J Med Food. 2005; 8: 125–132. https://doi.org/10.1089/jmf.2005.8.125 PMID: 16117603
4. Prakatthagomol W, Klayraung S, Okonogi S. Bactericidal action of Alpinia galanga essential oil on food-
borne bacteria. Drug Discov Ther. 2011; 5: 84–89. https://doi.org/10.5582/ddt.2011.v5.2.84 PMID:
22466145
SMEDDS and NE for Alpinia galanga oil
PLOS ONE | https://doi.org/10.1371/journal.pone.0188848 November 30, 2017 16 / 18
5. Yang X, Eilerman RG. Pungent principal of Alpinia galanga (L.) Swartz and its applications. J Agric
Food Chem. 1999; 47: 1657–1662. https://doi.org/10.1021/jf9808224 PMID: 10564034
6. Pikulkaew S, Khumpirapang N, Chaisri W, Okonogi S. Effects of Alpinia galanga oil on anesthesia and
stress reduction in Oreochromis niloticus. Drug Discov Ther. 2017; 11: 186–192. https://doi.org/10.
5582/ddt.2017.01035 PMID: 28867750
7. Bernstein PS, Digre KB, Creel DJ. Retinal toxicity associated with occupational exposure to the fish
anesthetic MS-222. Am J Ophthalmol. 1997; 124: 843–844. https://doi.org/10.1016/S0002-9394(14)
71705-2 PMID: 9402834
8. Carvan MJ, Loucks E, Weber DN, Williams FE. Ethanol effects on the developing zebrafish: neurobeha-
vior and skeletal morphogenesis. Neurotoxicol Teratol. 2004; 26: 757–768. https://doi.org/10.1016/j.
ntt.2004.06.016 PMID: 15451040
9. Krone P, Sass J, Lele Z. Heat shock protein gene expression during embryonic development of the zeb-
rafish. Cell Mol Life Sci. 1997; 53: 122–129. https://doi.org/10.1007/PL00000574 PMID: 9117992
10. Mathur P, Berberoglu MA, Guo S. Preference for ethanol in zebrafish following a single exposure.
Behav Brain Res. 2011; 217: 128–133. https://doi.org/10.1016/j.bbr.2010.10.015 PMID: 20974186
11. Chaudhary A, Nagaich U, Gulati N, Sharma V, Khosa R, Partapur MU. Enhancement of solubilization
and bioavailability of poorly soluble drugs by physical and chemical modifications: a recent review. J
Adv Pharm Educ Res. 2012; 2: 32–67.
12. Holm R, Porter CJH, Edwards GA, Mu¨llertz A, Kristensen HG, Charman WN. Examination of oral
absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administra-
tion in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur J
Pharm Sci. 2003; 20: 91–97. https://doi.org/10.1016/S0928-0987(03)00174-X PMID: 13678797
13. Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S. Formulation design for poorly water-soluble
drugs based on biopharmaceutics classification system: basic approaches and practical applications.
Int J Pharm. 2011; 420: 1–10. https://doi.org/10.1016/j.ijpharm.2011.08.032 PMID: 21884771
14. Zhao Y, Wang C, Chow AH, Ren K, Gong T, Zhang Z, et al. Self-nanoemulsifying drug delivery system
(SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studies. Int J Pharm.
2010; 383: 170–177. https://doi.org/10.1016/j.ijpharm.2009.08.035 PMID: 19732813
15. Bernardi DS, Pereira TA, Maciel NR, Bortoloto J, Viera GS, Oliveira GC, et al. Formation and stability of
oil-in-water nanoemulsions containing rice bran oil: in vitro and in vivo assessments. J Nanobiotechnol.
2011; 9: 1–9. https://doi.org/10.1186/1477-3155-9-44 PMID: 21952107
16. Donsı` F, Annunziata M, Sessa M, Ferrari G. Nanoencapsulation of essential oils to enhance their anti-
microbial activity in foods. LWT-Food Sci Technol. 2011; 44: 1908–1914. https://doi.org/10.1016/j.lwt.
2011.03.003
17. Eid AM, El-Enshasy HA, Aziz R, Elmarzugi NA. The preparation and evaluation of self-nanoemulsifying
systems containing Swietenia oil and an examination of its anti-inflammatory effects. Int J Nanomedi-
cine. 2014; 9: 4685–4695. https://doi.org/10.2147/IJN.S66180 PMCID: PMC4200018 PMID: 25336948
18. Wang X, Jiang Y, Wang YW, Huang MT, Ho CT, Huang Q. Enhancing anti-inflammation activity of cur-
cumin through O/W nanoemulsions. Food Chem. 2008; 108: 419–424. https://doi.org/10.1016/j.
foodchem.2007.10.086 PMID: 26059118
19. Okonogi S, Chaiyana W. Enhancement of anti-cholinesterase activity of Zingiber cassumunar essential
oil using a microemulsion technique. Drug Discov Ther. 2012; 6: 249–255. https://doi.org/10.5582/ddt.
2012.v6.5.249 PMID: 23229145
20. Oprean R, Oprean L, Tamas M, Sandulescu R, Roman L. Essential oils analysis. II. Mass spectra identi-
fication of terpene and phenylpropane derivatives. J Pharm Biomed Anal. 2001; 24: 1163–1168.
https://doi.org/10.1016/S0731-7085(00)00578-1 PMID: 11248515
21. Raina V, Srivastava S, Syamasunder K. Essential oil composition of Acorus calamus L. from the lower
region of the Himalayas. Flavour Fragr J. 2003; 18: 18–20. https://doi.org/10.1002/ffj.1136
22. Gardeli C, Vassiliki P, Athanasios M, Kibouris T, Komaitis M. Essential oil composition of Pistacia lentis-
cus L. and Myrtus communis L.: evaluation of antioxidant capacity of methanolic extracts. Food Chem.
2008; 107: 1120–1130. https://doi.org/10.1016/j.foodchem.2007.09.036
23. Zahl IH, Samuelsen O, Kiessling A. Anaesthesia of farmed fish: implications for welfare. Fish Physiol
Biochem. 2012; 38: 201–218. https://doi.org/10.1007/s10695-011-9565-1 PMID: 22160749
24. Jantan IB, Ahmad FB, Ahmad AS. Constituents of the rhizome and seed oils of Greater Galangal Alpinia
galanga (L.) Willd. from Malaysia. J Essent Oil Res. 2004; 16: 174–176. https://doi.org/10.1080/
10412905.2004.9698687
25. Raina V, Srivastava S, Syamasunder K. The essential oil of ‘greater galangal’[Alpinia galanga (L.)
Willd.] from the lower Himalayan region of India. Flavour Fragr J. 2002; 17: 358–360. https://doi.org/10.
1002/ffj.1105
SMEDDS and NE for Alpinia galanga oil
PLOS ONE | https://doi.org/10.1371/journal.pone.0188848 November 30, 2017 17 / 18
26. Charles DJ, Simon JE, Singh NK. The essential oil of Alpinia galanga Willd. J Essent Oil Res. 1992; 4:
81–82. https://doi.org/10.1080/10412905.1992.9698016
27. Mahae N, Chaiseri S. Antioxidant activities and antioxidative components in extracts of Alpinia galanga
(L.) SW. Kasetsart J Nat Sci. 2009; 43: 358–369.
28. Srivastava B, Singh P, Shukla R, Dubey NK. A novel combination of the essential oils of Cinnamomum
camphora and Alpinia galanga in checking aflatoxin B1 production by a toxigenic strain of Aspergillus
flavus. World J Microbiol Biotechnol. 2008; 24: 693–697. https://doi.org/10.1007/s11274-007-9526-0
29. Chalchat JC, O¨ zcan MM. Comparative essential oil composition of flowers, leaves and stems of basil
(Ocimum basilicum L.) used as herb. Food Chem. 2008; 110: 501–503. https://doi.org/10.1016/j.
foodchem.2008.02.018 PMID: 26049245
30. Wang Y, Sun J, Zhang T, Liu H, He F, He Z. Enhanced oral bioavailability of tacrolimus in rats by self-
microemulsifying drug delivery systems. Drug Dev Ind Pharm. 2011; 37: 1225–1230. https://doi.org/10.
3109/03639045.2011.565774 PMID: 21615281
31. Tenjarla S. Microemulsions: an overview and pharmaceutical applications. Crit Rev Ther Drug Carrier
Syst. 1999; 16: 461–521. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v16.i5.20 PMID:
10635455
32. Ho HO, Hsiao CC, Sheu MT. Preparation of microemulsions using polyglycerol fatty acid esters as sur-
factant for the delivery of protein drugs. J Pharm Sci. 1996; 85: 138–143. https://doi.org/10.1021/
js950352h PMID: 8683437
33. Zhang H, Yao M, Morrison RA, Chong S. Commonly used surfactant, Tween 80, improves absorption
of P-glycoprotein substrate, digoxin, in rats. Arch Pharm Res. 2003; 26: 768–772. https://doi.org/10.
1007/BF02976689 PMID: 14560928
34. Saupe A, Gordon KC, Rades T. Structural investigations on nanoemulsions, solid lipid nanoparticles
and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spec-
troscopy. Int J Pharm. 2006; 314: 56–62. https://doi.org/10.1016/j.ijpharm.2006.01.022 PMID:
16574354
35. Capek I. Degradation of kinetically-stable o/w emulsions. Adv Colloid Interface Sci. 2004; 107: 125–
155. https://doi.org/10.1016/S0001-8686(03)00115-5 PMID: 15026289
36. Solans C, Sole´ I. Nano-emulsions: formation by low-energy methods. Curr Opin Colloid Interface Sci.
2012; 17: 246–254. https://doi.org/10.1016/j.cocis.2012.07.003
37. McClements DJ. Edible nanoemulsions: fabrication, properties, and functional performance. Soft Mat-
ter. 2011; 7: 2297–2316. https://doi.org/10.1039/C0SM00549E
38. Marinova K, Alargova R, Denkov N, Velev O, Petsev D, Ivanov I, et al. Charging of oil-water interfaces
due to spontaneous adsorption of hydroxyl ions. Langmuir. 1996; 12: 2045–2051. https://doi.org/10.
1021/la950928i
39. Turek C, Stintzing FC. Stability of essential oils: a review. Compr Rev Food Sci Food Saf. 2013; 12:
40–53. https://doi.org/10.1111/1541-4337.12006
40. Cordes E, Bull H. Mechanism and catalysis for hydrolysis of acetals, ketals, and ortho esters. Chem
Rev. 1974; 74: 581–603. https://doi.org/10.1021/cr60291a004
41. Krishnan S, Bhosale R, Singhal RS. Microencapsulation of cardamom oleoresin: evaluation of blends of
gum arabic, maltodextrin and a modified starch as wall materials. Carbohydr Polym. 2005; 61: 95–102.
https://doi.org/10.1016/j.carbpol.2005.02.020
42. Mehyar GF, Al-Isamil KM, Al-Ghizzawi HM, Holley RA. Stability of cardamom (Elettaria Cardamomum)
essential oil in microcapsules made of whey protein isolate, guar gum, and carrageenan. J Food Sci.
2014; 79: 1939–1949. https://doi.org/10.1111/1750-3841.12652 PMID: 25224989
43. Aboalnaja KO, Yaghmoor S, Kumosani TA, McClements DJ. Utilization of nanoemulsions to enhance
bioactivity of pharmaceuticals, supplements, and nutraceuticals: nanoemulsion delivery systems and
nanoemulsion excipient systems. Expert Opin Drug Deliv. 2016; 21: 1–10. https://doi.org/10.1517/
17425247.2016.1162154 PMID: 26984045
44. Chaiyana W, Saeio K, Hennink WE, Okonogi S. Characterization of potent anticholinesterase plant oil
based microemulsion. Int J Pharm. 2010; 401: 32–40. https://doi.org/10.1016/j.ijpharm.2010.09.005
PMID: 20837121
45. Saeio K, Yotsawimonwat S, Anuchapreeda S, Okonogi S. Development of microemulsion of a potent
anti-tyrosinase essential oil of an edible plant. Drug Discov Ther. 2011; 5: 246–252. https://doi.org/10.
5582/ddt.2011.v5.5.246 PMID: 22466371
46. Sakulku U, Nuchuchua O, Uawongyart N, Puttipipatkhachorn S, Soottitantawat A, Ruktanonchai U.
Characterization and mosquito repellent activity of citronella oil nanoemulsion. Int J Pharm. 2009; 372:
105–111. https://doi.org/10.1016/j.ijpharm.2008.12.029 PMID: 19162149
SMEDDS and NE for Alpinia galanga oil
PLOS ONE | https://doi.org/10.1371/journal.pone.0188848 November 30, 2017 18 / 18
